These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2515030)

  • 1. Platelet aggregation and prostaglandin metabolites in the blood of patients with ischaemic heart disease during antiarrhythmic treatment.
    Kirichenko LL; Masenko VP; Gorshkov VA; Narynski AK; Kurakina TI; Morozova LM; Mamaev VI
    Cor Vasa; 1989; 31(5):355-64. PubMed ID: 2515030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of anti-arrhythmia preparations on thrombocytic and vascular hemostasis].
    Kirichenko LL; Masenko VP; Nikitin AE; Narynskiĭ AK; Morozova LM
    Ter Arkh; 1986; 58(6):70-2. PubMed ID: 3764717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of prolonged-action nitrates on platelet aggregation and prostaglandin formation].
    Kirichenko LL; Masenko VP; Evdokimova AG; Iunusov MA
    Kardiologiia; 1992 Apr; 32(4):8-10. PubMed ID: 1405245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study of the effect of ethacizin and lidocaine on the blood supply and function of the intact and ischemic myocardium].
    Goldshteĭne GKh; Chichkanov GG
    Biull Eksp Biol Med; 1984 Oct; 98(10):466-9. PubMed ID: 6498326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Changes in thrombocyte-vascular hemostasis and cyclic nucleotide levels after anti-arrhythmia therapy in patients with ischemic heart disease].
    Liusov VA; Dudaev VA; Borodkin VV; Rudakov AV
    Kardiologiia; 1989 Jan; 29(1):9-13. PubMed ID: 2733320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thrombocyte aggregation in patients with cardiac arrhythmias and effect of anti-arrhythmia agents].
    Kurbanov RD; Azimova NA; Kiakbaev GK; Abdullaev TA; Asriiants LS; Zakirov NU; Avezov DK; Faĭzullaev BP
    Kardiologiia; 1993; 33(5):27-9. PubMed ID: 7526023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molsidomine, a coronary drug with platelet-aggregating inhibitory activity].
    Silberbauer K; Slany J; Sinzinger H; Punzengruber C
    Z Kardiol; 1982 Aug; 71(8):539-43. PubMed ID: 6753382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of platelet function of antiarrhythmic drugs, verapamil and disopyramide.
    Han P; Boatwright C; Ardlie NG
    Thromb Haemost; 1982 Apr; 47(2):150-3. PubMed ID: 7101234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of bonnecor on cardiac hemodynamics, blood supply and function in experimental myocardial ischemia].
    Chichkanov GG; Tolmacheva EA; Lyskovtsev VV; Grigor'eva EK; Matsievskiĭ DD
    Farmakol Toksikol; 1990; 53(3):38-40. PubMed ID: 2387378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity.
    Murakami M; Kinukawa M; Kanazawa T; Maruyama K; Miyagi M; Miyata H; Ujiie A
    J Pharmacol Exp Ther; 1996 Nov; 279(2):877-83. PubMed ID: 8930195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Action of anti-arrhythmia agents in ischemia and hyperoxia].
    Kedrov SI; Reznikov KM; Leonov AN
    Farmakol Toksikol; 1988; 51(1):41-4. PubMed ID: 3360106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of ethmozin and Ritmilen on microcirculatory hemostasis in patients with heart rhythm disorders].
    Grigor'ev GI; Petrova TR
    Farmakol Toksikol; 1986; 49(5):94-7. PubMed ID: 3533622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostacyclin: haemodynamic and metabolic effects in patients with coronary artery disease.
    Bergman G; Daly K; Atkinson L; Rothman M; Richardson PJ; Jackson G; Jewitt DE
    Lancet; 1981 Mar; 1(8220 Pt 1):569-72. PubMed ID: 6110816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of lidocaine on thrombocytic hemostasis].
    Orlov VN; Kirilenko LL; Gorshkov VA; Vasil'eva EIu
    Kardiologiia; 1982 Dec; 22(12):79-82. PubMed ID: 7162030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of the new anti-arrhythmia preparation Bonnecor on the hemodynamics and activity of the ischemic heart].
    Tolmacheva EA; Chichkanov GG; Matsievskiĭ DD
    Biull Eksp Biol Med; 1989 May; 107(5):588-90. PubMed ID: 2736295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of selective thromboxane synthetase inhibitor OKY-046 on plasma prostaglandins in patients with coronary artery disease during exercise.
    Shikano M; Ogawa K; Ito T; Chen LS; Ito Y; Imaizumi M; Uno T; Tsutsumi S; Satake T
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():375-7. PubMed ID: 3159226
    [No Abstract]   [Full Text] [Related]  

  • 17. Enhanced platelet sensitivity to prostacyclin after isosorbide-5-mononitrate in patients with stable angina pectoris.
    Davì G; Cannizzaro S; Giubilato A; Novo S; Mattina A; Strano A
    Z Kardiol; 1986; 75 Suppl 3():80-2. PubMed ID: 3541421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of platelet aggregation, thromboxane A2 and prostacyclin in central aortic and coronary sinus blood in ischemic heart disease.
    Narain VS; Bhargava B; Chandra N; Puri VK; Hasan M
    Indian Heart J; 1994; 46(4):149-52. PubMed ID: 7875701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of class I anti-arrhythmia agents on the signal-averaged ECG].
    Goedel-Meinen L; Hofmann M; Schmidt G; Barthel P; Baedeker W; Blömer H
    Herz; 1988 Jun; 13(3):188-96. PubMed ID: 3136064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventing ventricular arrhythmias in ischemic heart disease.
    Ruffy R; Zipes DP
    Geriatrics; 1979 Jan; 34(1):21-5. PubMed ID: 103780
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.